Teva Pharmaceutical Industries (TEVA) News Today $16.74 -0.26 (-1.50%) Closing price 03:59 PM EasternExtended Trading$16.75 +0.00 (+0.01%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Up - Should You Buy?Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Up - Here's WhyFebruary 21 at 6:59 PM | marketbeat.comTeva Pharma and Alvotech launch US biosimilar to J&J's StelaraFebruary 21 at 6:44 AM | reuters.comTeva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.February 21 at 6:00 AM | globenewswire.comTeva Pharmaceutical Industries Ltd: Putting Patients First: Why Europe Must Act to Protect Access To MedicinesFebruary 20 at 10:53 AM | finanznachrichten.deBillionaire Stanley Druckenmiller Dumped Duquesne's Entire Stake in Broadcom and Bought One of Wall Street's Hottest Drug Stocks Hand Over FistFebruary 20 at 5:06 AM | fool.comTeva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Up - Still a Buy?Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Up - Time to Buy?February 19 at 9:53 PM | marketbeat.comTruist Financial Corp Sells 16,398 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Truist Financial Corp trimmed its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 1.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,372,424 shares of the company's stock after selling 16,398 sFebruary 19 at 4:56 AM | marketbeat.comTeva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)February 18 at 4:30 PM | globenewswire.comFDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's EyleaFebruary 18 at 11:30 AM | investopedia.comAlvotech and Teva’s BLA filing for AVT06 accepted by FDAFebruary 18 at 8:28 AM | markets.businessinsider.comAlvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)February 18 at 6:00 AM | globenewswire.comPinnbrook Capital Management LP Buys New Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Pinnbrook Capital Management LP purchased a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 225,320 shares of the company's stock, valued at approximatelyFebruary 18 at 5:34 AM | marketbeat.comAsset Management One Co. Ltd. Has $10.41 Million Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Asset Management One Co. Ltd. grew its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 14.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 457,371 shares of the company's stock after purchasing an adFebruary 18 at 3:35 AM | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Short Interest UpdateTeva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) saw a significant growth in short interest in January. As of January 31st, there was short interest totalling 22,360,000 shares, a growth of 41.5% from the January 15th total of 15,800,000 shares. Based on an average daily volume of 11,370,000 shares, the days-to-cover ratio is currently 2.0 days.February 17, 2025 | marketbeat.comTeva Pharm CEO calls on Trump for faster US drug approvalsFebruary 17, 2025 | msn.comTeva Pharm CEO calls for faster US generic drug approvalsFebruary 17, 2025 | reuters.comAllspring Global Investments Holdings LLC Buys 1,045,305 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Allspring Global Investments Holdings LLC raised its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 2,018.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,097,096 shares of the company's stock afterFebruary 16, 2025 | marketbeat.comAustralianSuper Pty Ltd Has $203.27 Million Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)AustralianSuper Pty Ltd boosted its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 16.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,222,695 shares oFebruary 15, 2025 | marketbeat.comVontobel Holding Ltd. Buys 58,772 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Vontobel Holding Ltd. raised its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 9.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 687,261 shares of the company'February 15, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by Van ECK Associates CorpVan ECK Associates Corp decreased its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 13.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,615,695 shares of theFebruary 15, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Position Raised by Kestra Private Wealth Services LLCKestra Private Wealth Services LLC raised its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 201.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 31,526 shares of the company'sFebruary 15, 2025 | marketbeat.comStanley Druckenmiller's Strategic Moves: A Closer Look at Teva Pharmaceutical Industries LtdFebruary 14, 2025 | gurufocus.comFMR LLC Increases Stake in Teva Pharmaceutical Industries LtdFebruary 12, 2025 | gurufocus.comWilmington Savings Fund Society FSB Has $636,000 Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Wilmington Savings Fund Society FSB lifted its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 945.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 28,850 shares of the company'sFebruary 11, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Has $52.22 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 20.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,369,302 shares of the company's stock afterFebruary 11, 2025 | marketbeat.comAxsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'February 10, 2025 | benzinga.comAxsome settles Auvelity patent litigation with TevaFebruary 10, 2025 | msn.comWCM Investment Management LLC Has $3.03 Million Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)WCM Investment Management LLC lifted its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 125.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 135,754 shares of tFebruary 10, 2025 | marketbeat.comCompletion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva PharmaceuticalsFebruary 10, 2025 | businesswire.comMarketBeat Week in Review – 02/03 - 02/07 (TEVA)Despite a Monday sell-off, stocks ended the week higher, and there's evidence that sector rotation is underway; next week's read of inflation may move markets.February 8, 2025 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by abrdn plcabrdn plc reduced its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 15.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 504,392 shares of the company's stock after selling 88,February 8, 2025 | marketbeat.comTeva files automatic mixed securities shelfFebruary 8, 2025 | markets.businessinsider.comDecoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT InsightFebruary 8, 2025 | gurufocus.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Stock Position Raised by Migdal Insurance & Financial Holdings Ltd.Migdal Insurance & Financial Holdings Ltd. lifted its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 2.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 26,035,422 shares of the company's stockFebruary 7, 2025 | marketbeat.comTeva Pharmaceutical Industries Full Year 2024 Earnings: EPS Misses ExpectationsFebruary 7, 2025 | finance.yahoo.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven analysts that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation andFebruary 7, 2025 | marketbeat.comPrivate Management Group Inc. Decreases Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Private Management Group Inc. decreased its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 7.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,181,665 shares of thFebruary 6, 2025 | marketbeat.comTeva Pharmaceutical snaps six straight sessions of lossesFebruary 5, 2025 | msn.comSaverOne 2014 awarded new contract with TevaFebruary 4, 2025 | markets.businessinsider.comTeva Pharma: Why This Generic Drug Giant Is a Smart Buy NowTeva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?February 3, 2025 | marketbeat.comCapital Insight Partners LLC Increases Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Capital Insight Partners LLC raised its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 190.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 40,617 shares of the compFebruary 2, 2025 | marketbeat.comRobeco Institutional Asset Management B.V. Raises Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Robeco Institutional Asset Management B.V. grew its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 7.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 498,309 shares of the company's stock afteFebruary 2, 2025 | marketbeat.comTeva Pharmaceutical (TEVA) Gets a Buy from Argus ResearchFebruary 1, 2025 | markets.businessinsider.comTeva Pharmaceutical Indus Options Trading: A Deep Dive into Market SentimentFebruary 1, 2025 | benzinga.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Purchased by Fifth Third BancorpFifth Third Bancorp grew its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 6,682.6% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 18,720 shares of the company's stock after acquiring an additional 18,444 shares durinJanuary 31, 2025 | marketbeat.comTeva’s Earnings Call: Growth Amid ChallengesJanuary 30, 2025 | tipranks.comUBS Group Issues Pessimistic Forecast for Teva Pharmaceutical Industries (NYSE:TEVA) Stock PriceUBS Group dropped their price objective on shares of Teva Pharmaceutical Industries from $30.00 to $27.00 and set a "buy" rating on the stock in a research report on Thursday.January 30, 2025 | marketbeat.comTeva Pharmaceutical: 2025 Guidance Sinks The Stock, But Presents An OpportunityJanuary 30, 2025 | seekingalpha.comTeva Pharmaceutical Industries (NYSE:TEVA) Shares Down 4.6% on Analyst DowngradeTeva Pharmaceutical Industries (NYSE:TEVA) Shares Down 4.6% After Analyst DowngradeJanuary 30, 2025 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Given New $26.00 Price Target at BarclaysBarclays cut their price target on shares of Teva Pharmaceutical Industries from $28.00 to $26.00 and set an "overweight" rating on the stock in a report on Thursday.January 30, 2025 | marketbeat.com Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address TEVA Media Mentions By Week TEVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼0.880.60▲Average Medical News Sentiment TEVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼219▲TEVA Articles Average Week Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TAK News ARGX News BNTX News SMMT News GMAB News ITCI News VTRS News MRNA News RDY News PCVX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
